Application of Irinotecan based on simulation screening as AIBP inhibitor

A technology of inhibitors and aspects, applied in the field of medical research, can solve problems such as the unclarification of amino acid sites in specific structures
CN110895960APending Publication Date: 2020-03-20NANTONG UNIVERSITY

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NANTONG UNIVERSITY
Publication Date
2020-03-20

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides an application of Irinotecan based on molecular docking and molecular dynamics simulation screening as an AIBP inhibitor, and the Irinotecan is used for inhibiting interaction between AIBP and apoA-I, so that cholesterol is inhibited from flowing out of cells. The invention also provides a method for Irinotecan as an AIBP inhibitor based on molecular docking and molecular dynamics simulation screening. The method comprises the following steps: obtaining an AIBP protein structure through homologous simulation, and downloading a small molecular structure data set for docking, a molecular docking process and molecular dynamics simulation in a ZINC database. According to the method, the structure of AIBP is obtained through homologous simulation, the virtual screening isconducted on FDA authenticated drugs through molecular docking and molecular dynamics simulation on the basis of the new thought of old drugs, and it is found that Irinotecan can be stably bonded toa bonding interface of AIBP and apoA-I; or cholesterol can be inhibited from flowing out of cells, and the new application of the Irinotecan is excavated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The invention belongs to the technical field of medical research, and specifically relates to the application of Irinotecan as an AIBP inhibitor based on molecular docking and molecular dynamics simulation screening and a simulation screening method. Background technique

[0002] Apo A-1 binding protein (AIBP) is a secreted protein that can bind to apoA-1. In recent years, a large number of studies have found that AIBP is related to the occurrence and development of cardiovascular diseases. Studies have confirmed that AIBP is highly expressed in myocardial tissue in patients with ischemic heart disease; AIBP can inhibit the occurrence and development of lipid metabolism disorders such as familial mixed hyperlipidemia; AIBP in the platelets of patients with deep vein thrombosis increases and inhibits thrombosis; AIBP can also regulate the cholesterol levels of human umbilical vein endothelial cells and zebrafish embryos, and inhibit vascular endothelial gro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More